8+ hour, 49+ min ago  (254+ words) Expands suite of capabilities to model human pathogenesis and functional recovery for neurodegenerative diseases NEW ORLEANS, May 26, 2026 /PRNewswire/ -- 28bio today announced the launch of the CNS-3 D Induced Alzheimer's Model, a brain organoid assay enabling researchers to evaluate whether therapeutic candidates…...

8+ hour, 14+ min ago  (194+ words) "Joining Lilly is a powerful next chapter for our science and our team," said Franz-Werner Haas, LL. D. , chief executive officer of Limma Tech. "Lilly's global development capabilities, manufacturing scale and long-standing commitment to patients with serious disease will enable us to…...

8+ hour, 29+ min ago  (358+ words) Bio Space Orsini to Serve as Contracted Specialty Pharmacy for Gilead's Hepcludex" (bulevirtide'gmod) Hepcludex" is a first-in-class entry inhibitor approved for the treatment of adults with chronic hepatitis delta (HDV) infection. ELK GROVE VILLAGE, Ill. , May 26, 2026 /PRNewswire/ -- Orsini, a leader in…...

8+ hour, 12+ min ago  (553+ words) Bio Space Independent Pharmaceutical Partners with Rx ERP to Complete Full ERP Transition Through New Hub Platform The partnership strengthens Independent Pharmaceutical's serialization, DSCSA compliance, reporting, and operational infrastructure as the company continues expanding in Rx and OTC distribution. SALT…...

10+ hour, 14+ min ago  (472+ words) Bio Space ZETA SURGICAL Announces First Commercial Deployment of Zeta TMS Navigation System at HOPE Therapeutics BOSTON, May 26, 2026 /PRNewswire/ -- ZETA SURGICAL today announced the first commercial deployment of its FDA-cleared Zeta TMS Navigation System. The system will be utilized at…...

10+ hour, 7+ min ago  (182+ words) DALLAS, May 26, 2026 /PRNewswire/ -- Koya Medical ("Koya"), an emerging medtech innovator advancing patient-centered solutions in vascular health, has announced its participation in the following investor conferences from June 2 to June 4, 2026: Andy Doraiswamy (CEO) and Damian Rippole (CFO) will highlight the company's…...

7+ hour, 56+ min ago  (163+ words) The allowed claims relate to a novel Bryoid composition designated B14 B, including methods of isolation, purification, and manufacture. The USPTO determined that the claimed Bryoid composition demonstrated novelty and non-obviousness over prior bryostatin-related art. The patent application is part of…...

14+ hour, 16+ min ago  (511+ words) PORTO, Portugal--(BUSINESS WIRE)--#BIA28--Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced the completion of the treatment period in its Phase 2b ACTIVATE study of BIA 28-6156 (pariceract) in patients with Parkinson's disease (PD) who have a…...

6+ hour, 55+ min ago  (540+ words) Bio Space Verastem Oncology Appoints Michael P. Bailey to its Board of Directors BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the appointment of Michael…...

13+ hour, 57+ min ago  (565+ words) Three major new research projects focus on faster diagnosis, inclusive research, and national collaboration VANCOUVER, BC and CALGARY, AB, May 25, 2026 /CNW/ - Researchers in British Columbia and Alberta are launching three powerful new brain research platforms that promise to change how…...